<DOC>
	<DOCNO>NCT00850187</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety autologous transplantation Bone Marrow Mesenchymal stem cell ( MSCs ) mix collagen I scaffold patient Knee cartilage defect osteoarthritis</brief_summary>
	<brief_title>Autologous Transplantation Mesenchymal Stem Cells ( MSCs ) Scaffold Full-thickness Articular Cartilage</brief_title>
	<detailed_description>Articular cartilage defect weak potential self-repair reduce mitotic capacity chondrocytes vivo . Because patient articular cartilage defect may progress osteoarthritis , defect need repair even though exact natural course remain obscure . Traditional method repair , micro fracture , perforation , abrasion arthroplasty , produce consistent satisfactory long term clinical result . Transplantation autologous bone marrow MSCs expand culture would promise approach repair articular cartilage defect human osteoarthritic knee . This method clinically straightforward perform autologous cell readily harvest expanded culture without lose capacity differentiate chondrocytes . The purpose study evaluate clinical result obtain autologous MSCs expand culture treatment full-thickness chondral defect human knee .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Age 45 60 , inclusive Normal axial alignment Stable kneeprevious ligament reconstruction , stable Intact articular cartilage posterior meniscal weightbearing zone Ability understand willingness tosign consent O.C.D OA calgran classification II , III Pregnant lactate Inflammatory arthritis Oral steriod , methotrexate Unable follow postoperative exercise regimen return evaluation</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Knee cartilage disease</keyword>
</DOC>